← Open Payments lookup

ALEX LAPASARAN: Open Payments

NPI 1134183494 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,801 in 75 payments from 11 companies in 2025. Trend: 2023 $9,265 · 2024 $15,302 · 2025 $16,801

Speaker / faculty: $11,340Travel & lodging: $3,007Food & beverage: $2,454
CompanyPaymentsAmount
Gilead Sciences, Inc.40$15,849
Madrigal Pharmaceuticals2$178
Novo Nordisk Inc3$156
GENZYME CORPORATION11$150
Boston Scientific Corporation1$147
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$91
Takeda Pharmaceuticals U.S.A., Inc.3$78
Phathom Pharmaceuticals, Inc.6$68
Aimmune Therapeutics, Inc.2$48
Regeneron Healthcare Solutions, Inc.1$19

Products named: Epclusa, Vemlidy, REZDIFFRA, DUPIXENT, Wegovy, TheraSphere Y90 Glass Microspheres 10 GBq, Livdelzi, XIFAXAN.

Industry payments across NV — which companies pay providers there.